Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HOOK2 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | B3GALT2 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | C4orf45 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | CD69 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | GPATCH11 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | CDKN2D | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | UBQLN1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | ENTPD5 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | GALE | FIMM | pan-cancer | AAC | -0.46 | 0.01 |
mRNA | HOPX | CCLE | pan-cancer | AAC | 0.12 | 0.01 |